HammondDAStojakovicJKatheN. Effectiveness and safety of magnesium replacement in critically ill patients admitted to the medical intensive care unit in an academic medical center: a retrospective, cohort study [published online July 13, 2017]. J Intensive Care Med. 2017. doi:10.1177/0885066617720631.
2.
KraftMDBtaicheIFSacksGSKudskKA. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health-Syst Pharm. 2005;62(16):1663–1682.
3.
ShechterMHodHChouraquiPKaplinskyERabinowitzB. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol. 1995;75(5):321–323.
4.
RaghuCPeddeswara RaoPSeshagiri RaoD. Protective effect of intravenous magnesium in acute myocardial infarction following thrombolytic therapy. Int J Cardiol. 1999;71(3):209–215.
5.
RasmussenHSMcNairPNorregardPBackerVLindenegOBalslevS. Intravenous magnesium in acute myocardial infarction. Lancet. 1986;1(8475):234–236.
6.
WoodsKLFletcherSRoffeCHaiderY. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1992;339(8809):1553–1558.
7.
FurlanettoTWFaulhaberGA. Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg. Arch Intern Med. 2011;171:1391–1392.
